Back to UBS Group AG UBS Group AG

QNRXQNRX
5 quarters

Position history for UBS Group AGUBS Group AG's holdings in QUOIN PHARMACEUTICALS LTD

UBS Group AG holds 6,772 shares of QNRX (QUOIN PHARMACEUTICALS LTD), worth $32,777 as of 2026-Q2. The position was increased (+169.6% shares).

Current Value

$32,777

Current Shares

6,772

Total Value Change

+$31,577

Total Shares Change

+6,642

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
6,772
+169.6%
$32,7770.0%$4.84
22
2026-Q1
Increased
2,512
+147x
$16,5790.0%$8.74
20
2025-Q4
Increased
17
+1600.0%
$2450.0%$13.50
12
2025-Q3
Decreased
1
-99.2%
$70.0%$7.04
0
2025-Q2
New
130
-
$1,2000.0%$9.27
17

Other major holders of QNRX: Woodline Partners LP, Aberdeen Group plc, MILLENNIUM MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used